Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;24(1):100-107.
doi: 10.1245/s10434-016-5582-8. Epub 2016 Sep 21.

Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer

Harveshp D Mogal  1 , Clancy Clark  1 , Rebecca Dodson  1 , Nora F Fino  2 , Marissa Howard-McNatt  3
Affiliations

Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer

Harveshp D Mogal et al. Ann Surg Oncol. 2017 Jan.

Abstract

Introduction: Survival in elderly patients undergoing mastectomy or lumpectomy has not been specifically analyzed.

Methods: Patients older than 70 years of age with clinical stage I invasive breast cancer, undergoing mastectomy or lumpectomy with or without radiation, and surveyed within 3 years of their diagnosis, were identified from the Surveillance, Epidemiology, and End Results and medicare health outcomes survey-linked dataset. The primary endpoint was breast cancer-specific survival (CSS).

Results: Of 1784 patients, 596 (33.4 %) underwent mastectomy, 918 (51.4 %) underwent lumpectomy with radiation, and 270 (15.1 %) underwent lumpectomy alone. Significant differences were noted in age, tumor size, American Joint Committee on Cancer (AJCC) stage, lymph node status (all p < 0.0001) and number of positive lymph nodes between the three groups (p = 0.003). On univariate analysis, CSS for patients undergoing lumpectomy with radiation [hazard ratio (HR) 0.61, 95 % confidence interval (CI) 0.43-0.85; p = 0.004] was superior to mastectomy. Older age (HR 1.3, 95 % CI 1.09-1.45; p = 0.002), two or more comorbidities (HR 1.57, 95 % CI 1.08-2.26; p = 0.02), inability to perform more than two activities of daily living (HR 1.61, 95 % CI 1.06-2.44; p = 0.03), larger tumor size (HR 2.36, 95 % CI 1.85-3.02; p < 0.0001), and positive lymph nodes (HR 2.83, 95 % CI 1.98-4.04; p < 0.0001) were associated with worse CSS. On multivariate analysis, larger tumor size (HR 1.89, 95 % CI 1.37-2.57; p < 0.0001) and positive lymph node status (HR 1.99, 95 % CI 1.36-2.9; p = 0.0004) independently predicted worse survival.

Conclusions: Elderly patients with early-stage invasive breast cancer undergoing breast conservation have better CSS than those undergoing mastectomy. After adjusting for comorbidities and functional status, survival is dependent on tumor-specific variables. Determination of lymph node status remains important in staging elderly breast cancer patients.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST Harveshp D. Mogal, Clancy Clark, Rebecca Dodson, Nora F. Fino, and Marissa Howard-McNatt have no conflicts of interest to declare.

Figures

FIG. 1
FIG. 1
a Overall and b breast cancer-specific survival based on treatment type
FIG. 2
FIG. 2
a, c Overall and b, d breast cancer-specific survival in node-negative and node-positive patients
FIG. 3
FIG. 3
a Overall and b breast cancer-specific survival—observed versus expected (age-matched controls)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, et al. SEER Cancer Statistics Review, 1975–2012, National Cancer Institute; Bethesda, MD, based on November 2014 SEER data submission, posted to the SEER web site, April 2015. http://seer.cancer.gov/csr/1975_2012/sections.html.
    1. Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41. - PubMed
    1. Lichter AS, Lippman ME, Danforth DN Jr, d’Angelo T, Steinberg SM, deMoss E, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol. 1992;10:976–83. - PubMed
    1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32. - PubMed
    1. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, et al. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg. 2009;209:425–33.e2. - PubMed

LinkOut - more resources